Photoreceptor layer thinning in idiopathic Parkinson's disease

This study was undertaken to quantify retinal and intra‐retinal layer thicknesses in Parkinson's disease (PD), and to evaluate whether retinal structural changes may be related to altered discrimination of color vision and to severity and duration of PD disease. We examined 97 PD patients and 32 healthy controls (HC) with spectral‐domain optical coherence tomography (OCT), including intra‐retinal layer segmentation. In total, we compared 111 retinal nerve fiber layer (RNFL)‐scans and 114 macula scans from 68 PD patients with 62 RNFL and 63 macula scans from 32 HC. For clinical evaluation of disease severity, we used the Unified Parkinson's Disease Rating Scale (UPDRS) motor examination. To determine color discrimination, we performed the Farnsworth Munsell 100 Hue Test (FMT) in a subgroup of PD patients. We found significant combined outer nuclear and photoreceptor layer thinning in PD versus HC (118.6 vs. 123.5 µm, P = 0.001). Differences in RNFL, total macular volume, or the other retinal layer thicknesses were not detected. The OCT measures were not associated with disease severity, duration, or color vision. By showing photoreceptor cell layer thinning, our findings support previous in vivo and autopsy studies demonstrating retinal alterations in PD. Optical coherence tomography may help to assess morphological retinal changes in PD patients; however, the utility of OCT in routine clinical practice may be limited because many PD patients have difficulties complying with OCT investigation because of disease‐related symptoms such as tremor, axial rigidity, or cognitive impairment. © 2014 International Parkinson and Movement Disorder Society

[1]  Axel Petzold,et al.  Distribution of retinal layer atrophy in patients with Parkinson disease and association with disease severity and duration. , 2014, American journal of ophthalmology.

[2]  Han-Joon Kim,et al.  Retinal nerve fiber layer thickness and visual hallucinations in Parkinson's Disease , 2014, Movement disorders : official journal of the Movement Disorder Society.

[3]  F. Ascaso,et al.  Development of a prediction formula of Parkinson disease severity by optical coherence tomography , 2014, Movement disorders : official journal of the Movement Disorder Society.

[4]  L. Pablo,et al.  Retinal thinning and correlation with functional disability in patients with Parkinson's disease , 2013, British Journal of Ophthalmology.

[5]  I. Bodis-Wollner,et al.  Correlation of Inner Retinal Thickness Evaluated by Spectral-Domain Optical Coherence Tomography and Contrast Sensitivity in Parkinson disease , 2013, Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society.

[6]  G. Ebersbach,et al.  Peripheral neuropathy in Parkinson's disease: levodopa exposure and implications for duodenal delivery. , 2013, Parkinsonism & related disorders.

[7]  K. Falavarjani,et al.  Retinal nerve changes in patients with tremor dominant and akinetic rigid Parkinson’s disease , 2013, Neurological Sciences.

[8]  Serkan Kirbas,et al.  Retinal Nerve Fiber Layer Thickness in Patients With Alzheimer Disease , 2013, Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society.

[9]  L. Pablo,et al.  Use of Fourier-domain OCT to detect retinal nerve fiber layer degeneration in Parkinson’s disease patients , 2013, Eye.

[10]  G. Rizzo,et al.  Loss of temporal retinal nerve fibers in Parkinson disease: a mitochondrial pattern? , 2013, European journal of neurology.

[11]  G. Hadjigeorgiou,et al.  Perimetric and retinal nerve fiber layer findings in patients with Parkinson’s disease , 2012, BMC Ophthalmology.

[12]  L. Pablo,et al.  Ability and reproducibility of Fourier-domain optical coherence tomography to detect retinal nerve fiber layer atrophy in Parkinson's disease. , 2012, Ophthalmology (Rochester, Minn.).

[13]  I. Bodis-Wollner,et al.  Interocular Asymmetry of Foveal Thickness in Parkinson Disease , 2012, Journal of ophthalmology.

[14]  Axel Petzold,et al.  The OSCAR-IB Consensus Criteria for Retinal OCT Quality Assessment , 2012, PloS one.

[15]  A. Schnitzler,et al.  Optical Coherence Tomography in Parkinsonian Syndromes , 2012, PloS one.

[16]  P. Villoslada,et al.  Color vision is strongly associated with retinal thinning in multiple sclerosis , 2012, Multiple sclerosis.

[17]  S. A. Meyer,et al.  Visual dysfunction in multiple sclerosis correlates better with optical coherence tomography derived estimates of macular ganglion cell layer thickness than peripapillary retinal nerve fiber layer thickness , 2011, Multiple sclerosis.

[18]  Amy Conger,et al.  The Impact of Utilizing Different Optical Coherence Tomography Devices for Clinical Purposes and in Multiple Sclerosis Trials , 2011, PloS one.

[19]  U. Mosimann,et al.  Retinal thickness in Parkinson's disease. , 2011, Parkinsonism & related disorders.

[20]  C. Pfueller,et al.  Impairment of contrast visual acuity as a functional correlate of retinal nerve fibre layer thinning and total macular volume reduction in multiple sclerosis , 2011, British Journal of Ophthalmology.

[21]  S. A. Meyer,et al.  Primary retinal pathology in multiple sclerosis as detected by optical coherence tomography. , 2011, Brain : a journal of neurology.

[22]  Joshua R. Ehrlich,et al.  Detection of retinal changes in Parkinson’s disease with spectral-domain optical coherence tomography , 2010, Clinical ophthalmology.

[23]  R. Krüger,et al.  Complex hyperkinetic movement disorders associated with POLG mutations , 2010, Movement Disorders.

[24]  I. Bodis-Wollner Retinopathy in Parkinson disease , 2009, Journal of Neural Transmission.

[25]  I. Bodis-Wollner,et al.  Inner retinal layer thinning in Parkinson disease. , 2009, Archives of ophthalmology.

[26]  Urs P Mosimann,et al.  The retina in Parkinson's disease. , 2009, Brain : a journal of neurology.

[27]  P. Witkovsky,et al.  Anatomical and neurochemical characterization of dopaminergic interplexiform processes in mouse and rat retinas , 2008, The Journal of comparative neurology.

[28]  Y. Çağlar,et al.  Correlation between retinal morphological and functional findings and clinical severity in Parkinson’s disease , 2008, Documenta Ophthalmologica.

[29]  R. Inzelberg,et al.  Retinal nerve fiber layer thinning in Parkinson disease , 2004, Vision Research.

[30]  H. Przuntek,et al.  Motor impairment influences Farnsworth-Munsell 100 Hue test error scores in Parkinson's disease patients , 2003, Journal of the Neurological Sciences.

[31]  L. Murri,et al.  Changes in Pattern Electroretinograms to Equiluminant Red-Green and Blue-Yellow Gratings in Patients with Early Parkinson’s Disease , 2003, Journal of clinical neurophysiology : official publication of the American Electroencephalographic Society.

[32]  Cynthia Owsley,et al.  Visual dysfunction, neurodegenerative diseases, and aging. , 2003, Neurologic clinics.

[33]  The Unified Parkinson's Disease Rating Scale (UPDRS): Status and recommendations , 2003, Movement disorders : official journal of the Movement Disorder Society.

[34]  A Sahraie,et al.  New Farnsworth-Munsell 100 hue test norms of normal observers for each year of age 5–22 and for age decades 30–70 , 2002, The British journal of ophthalmology.

[35]  S. Leurgans,et al.  Progressive worsening of spatial and chromatic processing deficits in Parkinson disease. , 2002, Archives of neurology.

[36]  H. Przuntek,et al.  Progress of visual dysfunction in Parkinson's disease , 2002, Acta neurologica Scandinavica.

[37]  H. Przuntek,et al.  Colour vision abnormalities do not correlate with dopaminergic nigrostriatal degeneration in Parkinson’s disease , 1998, Journal of Neurology.

[38]  M. Hankins,et al.  Neurobiology of retinal dopamine in relation to degenerative states of the tissue , 1997, Vision Research.

[39]  G. Bernardi,et al.  Visual alterations in de novo Parkinson's disease , 1995, Neurology.

[40]  W. Paulus,et al.  Predominant affection of the blue cone pathway in Parkinson's disease. , 1995, Brain : a journal of neurology.

[41]  J. Elias,et al.  Levodopa improves spatial contrast sensitivity in Parkinson's disease. , 1993, Archives of neurology.

[42]  R. Feldman,et al.  Abnormalities in color vision and contrast sensitivity in Parkinson's disease , 1992, Neurology.

[43]  J. Hughes,et al.  Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. , 1992, Journal of neurology, neurosurgery, and psychiatry.

[44]  T. Di Paolo,et al.  Decreased dopamine in the retinas of patients with Parkinson's disease. , 1990, Investigative ophthalmology & visual science.

[45]  H. Wagner,et al.  GABA and tyrosine hydroxylase immunocytochemistry reveal different patterns of colocalization in retinal neurons of various vertebrates , 1990, The Journal of comparative neurology.

[46]  M. Yahr,et al.  Visual dysfunction in Parkinson's disease. Loss in spatiotemporal contrast sensitivity. , 1987, Brain : a journal of neurology.

[47]  S Nightingale,et al.  Visual evoked cortical potentials and pattern electroretinograms in Parkinson's disease and control subjects. , 1986, Journal of neurology, neurosurgery, and psychiatry.

[48]  M. Ghilardi,et al.  Visual evoked potentials in parkinsonism and dopamine blockade reveal a stimulus-dependent dopamine function in humans. , 1986, Journal of neurology, neurosurgery, and psychiatry.

[49]  L. Maffei,et al.  Pattern ERG in the monkey after section of the optic nerve , 1986, Behavioural Brain Research.

[50]  V C Smith,et al.  Color-axis determination on the Farnsworth-Munsell 100-hue test. , 1985, American journal of ophthalmology.

[51]  E. Favale,et al.  VEP changes in Parkinson's disease are stimulus dependent. , 1984, Journal of neurology, neurosurgery, and psychiatry.

[52]  A. Laties,et al.  Dopaminergic neurons in the human retina , 1982, The Journal of comparative neurology.

[53]  J. Kassubek,et al.  Retinal single-layer analysis in Parkinsonian syndromes: an optical coherence tomography study , 2013, Journal of Neural Transmission.

[54]  F. Ozturk,et al.  The effect of levodopa and dopamine agonists on optic nerve head in Parkinson disease. , 2007, European journal of ophthalmology.

[55]  J. Nguyen‐Legros Functional neuroarchitecture of the retina: hypothesis on the dysfunction of retinal dopaminergic circuitry in Parkinson's disease , 2005, Surgical and Radiologic Anatomy.

[56]  Paul Witkovsky,et al.  Dopamine and retinal function , 2004, Documenta Ophthalmologica.

[57]  J. Friedman Ophthalmologic features of Parkinson's disease. , 2004, Neurology.

[58]  H. Przuntek,et al.  Loss of color vision during long-term treatment with pramipexole , 2003, Journal of Neurology.

[59]  M Tagliati,et al.  The pattern electroretinogram in Parkinson's disease reveals lack of retinal spatial tuning. , 1996, Electroencephalography and clinical neurophysiology.